MADISON, N.J., Jan. 8, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation is scheduled for Wednesday, January 9, 2013 at 2:30 p.m. Eastern Time.
The presentation will be webcast live during the conference and will be available to registered investors on the following site: http://jpmorgan.metameetings.com/webcasts/healthcare13/directlink?ticker=DGX and to the public on www.QuestDiagnostics.com/investor. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until February 9, 2013.
Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at QuestDiagnostics.com.
Kathleen Valentine (Investors): 973-520-2900
Wendy Bost (Media): 973-520-2800
SOURCE Quest Diagnostics Incorporated